BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9429285)

  • 1. Acute and chronic complications after implantation of a transjugular intrahepatic portosystemic shunt--a prospective study in 53 patients.
    Gschwantler M; Gebauer A; Vavrik J; Madani B; Rohrmoser M; Schrutka-Kölbl C; Brownstone E; Fleischer J; Tscholakoff D; Weiss W
    Z Gastroenterol; 1997 Nov; 35(11):999-1005. PubMed ID: 9429285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study.
    Domagk D; Patch D; Dick R; Grosso M; Rousseau H; Otal P; Goffette P; Heinecke A; Drees M; Domschke W; Menzel J
    Cardiovasc Intervent Radiol; 2002; 25(6):506-12. PubMed ID: 12183763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding.
    Bañares R; Casado M; Rodríguez-Láiz JM; Camúñez F; Matilla A; Echenagusía A; Simó G; Piqueras B; Clemente G; Cos E
    Am J Gastroenterol; 1998 Jan; 93(1):75-9. PubMed ID: 9448179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial.
    Henderson JM; Boyer TD; Kutner MH; Galloway JR; Rikkers LF; Jeffers LJ; Abu-Elmagd K; Connor J;
    Gastroenterology; 2006 May; 130(6):1643-51. PubMed ID: 16697728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ePTFE-covered stent-grafts for revision of obstructed transjugular intrahepatic portosystemic shunt.
    Cejna M; Peck-Radosavljevic M; Thurnher S; Schoder M; Rand T; Angermayr B; Lammer J
    Cardiovasc Intervent Radiol; 2002; 25(5):365-72. PubMed ID: 11981612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
    Membreno F; Baez AL; Pandula R; Walser E; Lau DT
    J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic shunt: efficacy for the treatment of portal hypertension and impact on liver transplantation.
    Cosenza CA; Hoffman AL; Friedman ML; Sher LS; Lopez RR; Van Allen R; Brown DH; Fraiman MH; Arnaout W; Vierling J; Makowka L
    Am Surg; 1996 Oct; 62(10):835-9. PubMed ID: 8813166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt.
    Russo MW; Jacques PF; Mauro M; Odell P; Brown RS
    Liver Transpl; 2002 Mar; 8(3):271-7. PubMed ID: 11910573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
    Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
    Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded PTFE-covered stent-grafts in the treatment of transjugular intrahepatic portosystemic shunt (TIPS) stenoses and occlusions.
    Echenagusia M; Rodriguez-Rosales G; Simo G; Camuñez F; Bañares R; Echenagusia A
    Abdom Imaging; 2005; 30(6):750-4. PubMed ID: 16245017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indicators for longterm survival after the transjugular portosystemic intrahepatic shunt procedure].
    Kirchhoff TD; Rosenthal H; Merkesdal S; Ockenga J; Manns MP; Galanski M; Caselitz M
    Radiologe; 2002 Sep; 42(9):745-52. PubMed ID: 12244477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
    Chung HH; Razavi MK; Sze DY; Frisoli JK; Kee ST; Dake MD; Hellinger JC; Kang BC
    J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding.
    Lo GH; Liang HL; Chen WC; Chen MH; Lai KH; Hsu PI; Lin CK; Chan HH; Pan HB
    Endoscopy; 2007 Aug; 39(8):679-85. PubMed ID: 17661241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.
    Baron A; Gulberg V; Sauter G; Waggershauser T; Reiser M; Gerbes AL
    Hepatogastroenterology; 1998; 45(24):2315-21. PubMed ID: 9951915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent position of transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension.
    Svoboda P; Kantorova I; Brhelova H; Vasickova J; Ochmann J
    Hepatogastroenterology; 1997; 44(15):647-55. PubMed ID: 9222665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): Long-term follow-up of 100 patients.
    Rössle M; Siegerstetter V; Euringer W; Olschewski M; Kromeier J; Kurz K; Langer M
    Acta Radiol; 2006 Sep; 47(7):660-6. PubMed ID: 16950701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.